SLS BIO Co., Ltd (KOSDAQ:246250)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,969.00
+85.00 (4.51%)
At close: Jun 9, 2025

SLS BIO Revenue

In the year 2025, SLS BIO had annual revenue of 3.98B KRW, down -52.41%. SLS BIO had revenue of 341.10M in the quarter ending December 31, 2025, a decrease of -81.35%.

Revenue
3.98B
Revenue Growth
-52.41%
P/S Ratio
6.75
Revenue / Employee
n/a
Employees
n/a
Market Cap
26.89B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20253.98B-4.39B-52.41%
Dec 31, 20248.37B-652.10M-7.23%
Dec 31, 20239.02B-1.73B-16.08%
Dec 31, 202210.75B4.54B73.02%
Dec 31, 20156.21B393.13M6.75%
Dec 31, 2014 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
BioInfra 23.15B
C&R Research 64.98B
DT&CRO CO. 47.75B
WOOJUNG BIO 37.59B
Curachem 6.02B
P&K Skin Research Center 22.78B
HLB bioStep 74.05B
Cronex.Co.,Ltd 1.03B
Revenue Rankings